In this issue:
Enabling direct oral challenge in patients with low-risk penicillin allergy
Natural course of pollen-induced allergic rhinitis
Adaptive immune responses in hyper-vaccinated individuals
COVID-19 vaccination in patients with inborn errors of immunity
Anti-interleukin-23 autoantibodies in adult-onset immunodeficiency
Benralizumab versus meprolizumab for eosinophilic granulomatosis
Omalizumab for the treatment of multiple food allergies
In-vivo gene editing of KLKB1 for hereditary angioedema
Cellular architecture shapes the naïve T cell response
Anaphylaxis advances in the last ten years
Please login below to download this issue (PDF)